Edition:
United States

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

3.65USD
22 Sep 2017
Change (% chg)

$0.20 (+5.80%)
Prev Close
$3.45
Open
$3.45
Day's High
$3.65
Day's Low
$3.35
Volume
15,428
Avg. Vol
9,826
52-wk High
$3.65
52-wk Low
$2.25

Chart for

About

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization,... (more)

Overall

Beta: 1.13
Market Cap(Mil.): $127.15
Shares Outstanding(Mil.): 34.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 175.94 16.34
EPS (TTM): -- -- --
ROI: -- 9.47 14.66
ROE: -- 14.70 14.00

BRIEF-Harvard Bioscience says First Light Asset Management reports 10.3 pct passive stake in Harvard - SEC Filing

* First Light Asset Management Reports 10.3 Pct Passive Stake In Harvard Bioscience Inc As of june 30 - SEC Filing Source text for Eikon: Further company coverage:

Jul 07 2017

BRIEF-Harvard Bioscience elects James Green as chairman of board

* Harvard Bioscience elects James Green as chairman of board of directors Source text for Eikon: Further company coverage:

Jun 07 2017

BRIEF-Harvard Bioscience reports Q1 non-GAAP earnings $0.02/shr

* Harvard Bioscience reports first quarter 2017 financial results

Apr 27 2017

Earnings vs. Estimates